Organisation paid for research Program year 2025 Source: CMS Open Payments

Mills Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$1,877,834

234 payments

Through program year 2025, Mills Clinical Research is reported as receiving $1,877,834 in research payments, across 234 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $716,875 77
2024 Research $64,928 6
2023 Research $533,467 63
2022 Research $118,039 33
2021 Research $53,910 16
2020 Research $62,063 18
2019 Research $328,552 21

Breakdown

Who paid Research payments · program years 2019–2025
  1. Roche Molecular Systems, Inc. $1,147,225 108 payments
  2. ViiV Healthcare Company $523,664 91 payments
  3. Merck Sharp & Dohme Corporation $98,145 2 payments
  4. Theratechnologies Inc. $68,634 15 payments
  5. Moderna TX, Inc. $39,192 17 payments
  6. GlaxoSmithKline, LLC. $974 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Rd007113 $496,597 41 payments
  2. Rd005944 $365,243 42 payments
  3. Phase IV, Single-Arm, Open-Label Study Evaluating Bone Mineral Density $260,042 1 payment
  4. A Phase Iiib, Randomized, Multicenter, Parallel-Group, Non-Inferiority $214,162 68 payments
  5. Rd007234 $122,197 13 payments
  6. Rd005943 $115,094 10 payments
  7. A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to Doravirine,Islatravir DOR,ISL 100 mg,0.25 mg Once-Daily in Participants With HIV-1 Who Are Virologically Suppressed on Bictegravir,Emtricitabine,Tenofovir Alafenamide BIC,FTC,TAF $98,145 2 payments
  8. A Phase 3 Study of the Safety of Trogarzo Administered as an Undiluted IV Push over a Reduced Interval or as an Intramuscular Injection in Clinically Stable HIV-1 Infected Trogarzo Experienced Patients and Healthy HIV-uninfected Volunteers $48,601 7 payments
  9. Rd007314 $48,095 2 payments
  10. A Phase 2B Single Arm, Repeat Dose Study to Evaluate the Pharmacokinet $47,452 20 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record